Vimta Labs Limited

Vimta Labs Limited (VIMTALABS) is a micro-cap Healthcare company valued at ₹2,338 crore operating in Healthcare Research, Analytics & Technology on the NSE and BSE.

Recent price move

Vimta Labs Limited last traded at ₹523.55, modestly up 0.36% on the day.

Recent developments

On 2026-06-18, the company announced a dividend of ₹2.00 per share, with the ex-date set for that day. The promoter holding decreased by 0.18 percentage points in the quarter, while foreign institutional holdings fell by 0.47 percentage points and domestic institutional holdings increased by 0.23 percentage points.

Financial performance

The company's business has improved, with annual revenue rising 18.4% and annual net profit growing 15.7%. The latest quarter showed revenue and net profit both rising 11.3% and 10.7% respectively compared to the same quarter a year earlier, though the net profit margin narrowed slightly to 19.0% from 19.5%.

Valuation multiples

The stock trades at 30.1 times earnings, broadly in line with the Healthcare median of 32.0, 6.21 times book value. It yields 0.3%.

Things to watch

The stock is 24.6% below its 52-week high, and the net profit margin has narrowed by 0.4 percentage points. The promoter holding has also declined slightly in the quarter, which may indicate a shift in ownership dynamics.

Where it stands

The company has shown consistent revenue and profit growth over the past five years, with recent quarterly results reflecting continued expansion. The most significant movement is the stock's distance below its 52-week high, which highlights recent underperformance relative to its peak.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.